0
0
38 words
0
Comments
AstraZeneca (AZN) reported strong earnings Friday, including $22 billion, or 4% revenue growth, in the first half of the year, and kept its 2023 forecast...
You are the first to view
https://finance.yahoo.com/news/astrazeneca-plays-up-china-downplays-patent-loss-in-latest-earnings-cfo-185028966.html
Create an account or login to join the discussion